Related Experiment Video
Updated: Dec 12, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Amplifying the Noise: Oncometabolites Mask an Epigenetic Signal of DNA Damage
Milan R Savani1, Kalil G Abdullah2, Samuel K McBrayer3
1Medical Scientist Training Program, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Abstract:
A recent study (Sulkowski et al., 2020) reveals that oncometabolites, which are produced by metabolic gene mutations in many cancers, sensitize cells to PARP inhibition by antagonizing histone demethylation and obscuring epigenetic marks that are necessary for efficient DNA repair.
Insights
Cancer cells with oncometabolites become more sensitive to PARP inhibitors. This occurs because oncometabolites interfere with epigenetic marks essential for DNA repair processes.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Metabolic gene mutations in cancer can lead to the production of oncometabolites.
- Efficient DNA repair is crucial for cancer cell survival and response to therapy.
- Epigenetic modifications play a vital role in regulating gene expression and DNA repair.
Purpose of the Study:
- To investigate the role of oncometabolites in cancer cell sensitivity to PARP inhibition.
- To elucidate the underlying molecular mechanisms by which oncometabolites affect DNA repair and drug response.
Main Methods:
- The study analyzed the effects of oncometabolites on cellular processes related to DNA repair.
- Researchers examined the interaction between oncometabolites, histone demethylation, and epigenetic marks.
Main Results:
- Oncometabolites were found to sensitize cancer cells to PARP inhibition.
- Oncometabolites antagonize histone demethylation, disrupting necessary epigenetic marks.
- This disruption impairs efficient DNA repair pathways in cancer cells.
Conclusions:
- Oncometabolites represent a key factor in determining cancer cell response to PARP inhibitors.
- Targeting oncometabolite production or their downstream effects could offer novel therapeutic strategies in oncology.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair

